High Blood Pressure & Cardiovascular Prevention

, Volume 17, Issue 4, pp 227–233 | Cite as

The Relationship between an Oxidative Stress Biomarker and Plasma Haemoglobin in Patients with Chronic Kidney Disease

  • Raffaella Riccobene
  • Rosalia Arsena
  • Giuseppe Mulè
  • Francesco Vaccaro
  • Chiara Altieri
  • Francesca Tornese
  • Alessandra Ocello
  • Giovanni Cerasola
  • Santina Cottone
Original Research Article


Introduction: Evidence suggests that decreased haemoglobin plasma concentration may be a predictor of adverse cardiovascular events in patients with chronic kidney disease (CKD). We hypothesized that in CKD patients, oxidative stress could influence the development of cardiovascular damage via a relationship with haemoglobin levels.

Methods: We assayed plasma levels of the biomarker of oxidative stress 8-ISO-prostaglandin F2α (8-ISO-PGF2α) and of haemoglobin in 193 stage 2–5 CKD patients, investigating their relationship. Eighty healthy subjects and 80 patients with primary hypertension having normal renal function were enrolled as controls.

Results: The CKD group was divided according to 8-ISO-PGF2α quartiles, and decreasing levels of both haemoglobin and estimated glomerular filtration rate (eGFR) along with increasing quartiles were observed. In the 193 CKD patients, the linear analysis of correlation showed inverse correlations of 8-ISO-PGF2α with both haemoglobin and eGFR (r = −0.47; r = −0.81; p < 0.00001, respectively). In the control groups, no correlation between haemoglobin and 8-ISO-PGF2α was found. The multiple regression analysis carried out in CKD patients, by a model with 8-ISO-PGF2α as the dependent variable, and including haemoglobin and all confounding factors, confirmed the inverse relationship between haemoglobin and 8-ISO-PGF2α (β = −0.50; p < 0.00001). In this model, only when eGFR was added did the relationship between haemoglobin and 8-ISO-PGF2α lose statistical significance. In this final multivariate model, 8-ISO-PGF2α correlated independently with eGFR (β = −0.82; p < 0.0001).

Conclusions: In CKD, haemoglobin plasma level is inversely related to oxidative stress, depending on GFR. It remains to be elucidated whether or not the biochemistry of nitric oxide and haemoglobin interaction has a role in causing this relationship.


haemoglobin anaemia oxidative stress kidney disease isoprostanes 



There are no conflicts of interest to declare. This work was in part conducted with a grant from the Italian Ministry of Research (ex MURST).


  1. 1.
    Parfrey P. Anaemia in chronic renal disease: lessons learned since Seville 1994. Nephrol Dial Transplant 2001; 16: 41–5PubMedCrossRefGoogle Scholar
  2. 2.
    Sarnak MJ, Tighiouart H, Manjunath G, et al. Anemia as a risk factor for cardiovascular disease in the Atherosclerosis Risk in Communities (ARIC) study. J Am Coll Cardiol 2002; 40: 27–33PubMedCrossRefGoogle Scholar
  3. 3.
    Abramson JL, Jurkovitz CT, Vaccarino V, et al. Chronic kidney disease, anemia, and incident stroke in a middle-aged, community-based population: the ARIC study. Kidney Int 2003; 64: 610–5PubMedCrossRefGoogle Scholar
  4. 4.
    Astor BC, Coresh J, Heiss G, et al. Kidney function and anemia as risk factors for coronary heart disease and mortality: the Atherosclerosis Risk in Communities (ARIC) study. Am Heart J 2006; 151(2): 492–500PubMedCrossRefGoogle Scholar
  5. 5.
    Olsen M, Wachtell K, Beevers G, et al. Prognostic importance of hemoglobin in hypertensive patients with electrocardiographic left ventricular hypertrophy: the Losartan Intervention For End point reduction in hypertension (LIFE) study. Am Heart J 2009; 157: 177–84PubMedCrossRefGoogle Scholar
  6. 6.
    Gow AJ, Luchsinger BP, Pawloski JR, et al. The oxyhemoglobin reaction of nitric oxide. Proc Natl Acad Sci USA 1999; 96: 9027–32PubMedCrossRefGoogle Scholar
  7. 7.
    Singel DJ, Stamler JS. Chemical physiology of blood flow regulation by red blood cells: the role of nitric oxide and S-nitrosohemoglobin. Annu Rev Physiol 2005; 67: 99–145PubMedCrossRefGoogle Scholar
  8. 8.
    Cottone S, Mule G, Nardi E, et al. Relation of C-reactive protein to oxidative stress and to endothelial activation in essential hypertension. Am J Hypertens 2006 Mar; 19(3): 313–8PubMedCrossRefGoogle Scholar
  9. 9.
    Cottone S, Mule G. Endothelin-1 and F2-isoprostane relate to and predict renal dysfunction in hypertensive patients. Nephrol Dial Transplant 2009; 24: 497–503PubMedCrossRefGoogle Scholar
  10. 10.
    Cottone S, Palermo A, Vaccaro F, et al. Oxidative stress and inflammation in long-term renal transplanted hypertensives. Clin Nephrol 2006 Jul; 66(1): 32–8PubMedGoogle Scholar
  11. 11.
    Patrono C, FitzGerald GA. Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler Thromb Vasc Biol 1997; 17: 2309–15PubMedCrossRefGoogle Scholar
  12. 12.
    Morrow JD. Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans. Arterioscler Thromb Vasc Biol 2005; 25: 279–86PubMedCrossRefGoogle Scholar
  13. 13.
    National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification and stratification. Am J Kidney Dis 2002; 39 Suppl. 1: S1–266Google Scholar
  14. 14.
    Levey AS, Greene T, Kusek J, etal. A simplified equation to predict glomerular filtration rate from serum creatinine [abstract]. J Am Soc Nephrol 2000; 11: 155AGoogle Scholar
  15. 15.
    Mancia G, De Backer G, Dominiczak A, et al. The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2007 Guidelines for the management of arterial hypertension. J Hypertens 2007; 25: 1105–87PubMedCrossRefGoogle Scholar
  16. 16.
    Morrow JD, Hill KA, Burk RF, et al. A series of prostaglandin F2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radicalcatalyzed mechanism. Proc Natl Acad Sci U S A 1990; 87: 9383–7PubMedCrossRefGoogle Scholar
  17. 17.
    Takahashi K, Nammour TM, Fukunaga M, et al. Glomerular actions of a free radical generated novel prostaglandin, 8-epi-prostaglandinF2a, in the rat. J Clin Invest 1992; 90: 136–41PubMedCrossRefGoogle Scholar
  18. 18.
    Famm SS, Morrow JD. The isoprostanes: unique products of arachidonic acid oxidation: a review. Curr Med Chem 2003; 10: 1723–40CrossRefGoogle Scholar
  19. 19.
    Morrow JD, Roberts LJ. Mass spectrometric quantification of F2-isoprostanes in biological fluids and tissues as measure of oxidant stress. Methods Enzymol 1999; 300: 3–12PubMedCrossRefGoogle Scholar
  20. 20.
    Roberts LJ, Morrow JD. Measurement of F2-isoprostanes an index of oxidative stress in vivo. Free Radic Biol Med 2000; 28: 505–13PubMedCrossRefGoogle Scholar
  21. 21.
    Go AS, Yang J, Ackerson LM, et al. Hemoglobin level, chronic kidney disease, and the risks of death and hospitalization in adults with chronic heart failure. The Anemia in Chronic Heart Failure: Outcomes and Resource Utilization (ANCHOR) Study. Circulation 2006; 113: 2713–23PubMedCrossRefGoogle Scholar
  22. 22.
    Chade AR, Lerman A, Lerman LO. Kidney in early atherosclerosis. Hypertension 2005; 45: 1042–9PubMedCrossRefGoogle Scholar
  23. 23.
    Gow AJ. Nitric oxide, hemoglobin, and hypoxic vasodilation. Am J Respir Cell Mol Biol 2005 Jun; 32(6): 479–82PubMedCrossRefGoogle Scholar
  24. 24.
    Patel TV, Mittal BV, Keithi-Reddy SR, et al. Endothelial activation markers in anemic non-dialysis chronic kidney disease patients. Nephron Clin Pract 2008; 110: c244–50PubMedCrossRefGoogle Scholar
  25. 25.
    Verbeke FH, Agharazii M, Boutouyrie P, et al. Local shear stress and brachial artery functions in end-stage renal disease. J Am Soc Nephrol 2007; 18: 621–8PubMedCrossRefGoogle Scholar

Copyright information

© Adis Data Information BV 2010

Authors and Affiliations

  • Raffaella Riccobene
    • 1
  • Rosalia Arsena
    • 2
  • Giuseppe Mulè
    • 1
  • Francesco Vaccaro
    • 2
  • Chiara Altieri
    • 2
  • Francesca Tornese
    • 2
  • Alessandra Ocello
    • 2
  • Giovanni Cerasola
    • 1
  • Santina Cottone
    • 2
  1. 1.Cattedra di Medicina Interna, Dipartimento di Medicina Interna, Malattie Cardiovascolari e NefroUrologicheUniversità degli Studi di PalermoPalermoItaly
  2. 2.Cattedra di Nefrologia, Dipartimento di Medicina Interna, Malattie Cardiovascolari e NefroUrologicheUniversità degli Studi di PalermoPalermoItaly

Personalised recommendations